Evidence map›Paper›PMID 11183446›Full record

ArticleHealth care analysis : HCA : journal of health philosophy and policy2000

Commodification arguments for the legal prohibition of organ sale.

S Wilkinson

Abstract read
PubMed Publisher
In one paragraph

Article in Health care analysis : HCA : journal of health philosophy and policy, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. On Replacement Body Parts.Journal of bioethical inquiry · 2019
    Article
  5. Compensation for Blood Plasma Donation as a Distinctive Ethical Hazard: Reformulating the Commodification Objection.HEC forum : an interdisciplinary journal on hospitals' ethical and legal issues · 2015
    Article
  6. Persons and their parts: new reproductive technologies and risks of commodification.Health care analysis : HCA : journal of health philosophy and policy · 2009
    Article
  7. Article
  8. The commercialization of human stem cells: ethical and policy issues.Health care analysis : HCA : journal of health philosophy and policy · 2002
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

S WilkinsonDepartment of Philosophy, Keele University, Staffordshire, UK. s.wilkinson@phil.keele.ac.uk

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The commercial trading of human organs, along with various related activities (for example, advertising) was criminalised throughout Great Britain under the Human Organ Transplants Act 1989. This paper critically assesses one type of argument for this, and similar, legal prohibitions: commodification arguments. Firstly, the term 'commodification' is analysed. This can be used to refer to either social practices or to attitudes. Commodification arguments rely on the second sense and are based on the idea that having a commodifying attitude to certain classes of thing (e.g. bodies or persons) is wrong. The commodifying attitude consists of three main elements: denial of subjectivity, instrumentality, and fungibility. Secondly, in the light of this analysis, the claim that organ sale involves commodifying the human body is examined. This claim is found to be plausible but insufficient to ground an argument against organ sale, because the very same commodifying attitude is likely to be present in cases of (unpaid) organ donation. It is also argued that commodifying bodies per se may not be wrong. Thirdly, the view that organ sale involves commodifying persons is examined. Although this and the claim that it is wrong to commodify persons are probably true, there is--it is argued--little reason to regard organ sale as worse in this respect than other widely accepted practices, such as the buying and selling of labour. The conclusion is that although commodification is a useful ethical concept and although commodification arguments may sometimes be successful, the commodification argument against organ sale is not persuasive. This is not to say, though, that there are no arguments for prohibition--simply that this particular justificatory strategy is flawed.

Indexed as

CommodificationGift GivingHuman BodyCommerceCriminal LawHumansOwnershipTissue and Organ ProcurementTissue DonorsTransplantsUnited KingdomAnalytical ApproachHealth Care and Public HealthLegal Approach

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.